Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Zeiser

Showing results (291-300 of 334) with videos related to

Pageof 34
Sort By:
Nature Communications|March 27, 2019
Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCTMaddalena Noviello, Francesco Manfredi, Eliana Ruggiero, et al.
Blood|March 28, 2015
The IL-33/ST2 axis augments effector T-cell responses during acute GVHDDawn K Reichenbach, Vincent Schwarze, Benjamin M Matta, et al.
Nature Communications|January 10, 2024
Prostaglandin E<sub>2</sub> controls the metabolic adaptation of T cells to the intestinal microenvironmentMatteo Villa, David E Sanin, Petya Apostolova, et al.
Blood|September 20, 2019
Danger-associated extracellular ATP counters MDSC therapeutic efficacy in acute GVHDBrent H Koehn, Asim Saha, Cameron McDonald-Hyman, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Prostaglandin E <sub>2</sub> controls the metabolic adaptation of T cells to the intestinal microenvironmentMatteo Villa, David E Sanin, Petya Apostolova, et al.
Frontiers in Immunology|November 15, 2023
Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 studyArmin Gerbitz, Regina Gary, Michael Aigner, et al.
Signal Transduction and Targeted Therapy|January 16, 2026
Vertical RAS pathway inhibition in pancreatic cancer drives therapeutically exploitable mitochondrial alterationsPhilipp Hafner, Steffen J Keller, Xun Chen, et al.
The Journal of Clinical Investigation|September 30, 2025
Acetyl-CoA carboxylase 1 inhibition increases Treg metabolism and graft-versus-host disease treatment efficacy via mitochondrial fusionCameron McDonald-Hyman, Ethan G Aguilar, Ewoud B Compeer, et al.
Blood Advances|March 31, 2025
AhR activation mitigates graft-versus-host disease of the central nervous system by reducing microglial NF-κB signalingAlexander Zähringer, Inês Morgado, Daniel Erny, et al.
Bone Marrow Transplantation|September 10, 2025
Improved GVHD-free relapse-free survival when rATG/ATLG is used in allo-HCT from matched sibling donors - an EBMT registry study by the Transplant Complications Working PartyAgnieszka Piekarska, Mouad Abouqateb, William Boreland, et al.
Pageof 34

Showing results (291-300 of 334) with videos related to

Sort By:
Pageof 34
Nature Communications|March 27, 2019
Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCTMaddalena Noviello, Francesco Manfredi, Eliana Ruggiero, et al.
Blood|March 28, 2015
The IL-33/ST2 axis augments effector T-cell responses during acute GVHDDawn K Reichenbach, Vincent Schwarze, Benjamin M Matta, et al.
Nature Communications|January 10, 2024
Prostaglandin E<sub>2</sub> controls the metabolic adaptation of T cells to the intestinal microenvironmentMatteo Villa, David E Sanin, Petya Apostolova, et al.
Blood|September 20, 2019
Danger-associated extracellular ATP counters MDSC therapeutic efficacy in acute GVHDBrent H Koehn, Asim Saha, Cameron McDonald-Hyman, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Prostaglandin E <sub>2</sub> controls the metabolic adaptation of T cells to the intestinal microenvironmentMatteo Villa, David E Sanin, Petya Apostolova, et al.
Frontiers in Immunology|November 15, 2023
Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 studyArmin Gerbitz, Regina Gary, Michael Aigner, et al.
Signal Transduction and Targeted Therapy|January 16, 2026
Vertical RAS pathway inhibition in pancreatic cancer drives therapeutically exploitable mitochondrial alterationsPhilipp Hafner, Steffen J Keller, Xun Chen, et al.
The Journal of Clinical Investigation|September 30, 2025
Acetyl-CoA carboxylase 1 inhibition increases Treg metabolism and graft-versus-host disease treatment efficacy via mitochondrial fusionCameron McDonald-Hyman, Ethan G Aguilar, Ewoud B Compeer, et al.
Blood Advances|March 31, 2025
AhR activation mitigates graft-versus-host disease of the central nervous system by reducing microglial NF-κB signalingAlexander Zähringer, Inês Morgado, Daniel Erny, et al.
Bone Marrow Transplantation|September 10, 2025
Improved GVHD-free relapse-free survival when rATG/ATLG is used in allo-HCT from matched sibling donors - an EBMT registry study by the Transplant Complications Working PartyAgnieszka Piekarska, Mouad Abouqateb, William Boreland, et al.
Pageof 34